-transparent.png){kind=logo}
The ovarian-hormone-induced leukaemias of strain ICRC mice, with an abundance of intracytoplasmic type A particles in primary as well as transplanted lesions, were used to study morphological, biophysical, immunological and structural characteristics of type A particles. Mammary tumours of strains ICRC and C3H(Jax) were also used as sources for type A particles. The purified virions banded at the density of 1.20 g/ml in 12--60% linear sucrose-density gradient when subjected to spinning at 113,000 g for 4 h. The SDS-polyacrylamide-gel electrophoresis of type A particles from mammary tumours and leukaemias reproducibly resolved at least 8 polypeptides, 2 of these 54,000 and 24,000 dalton proteins, showing variable expression. Type A particles and B particles, despite the fact that each had a distinct polypeptide pattern, showed common antigens with different electrophoretic mobilities. Proteins of 24,000, 18,000 and 12,000 daltons from B particles were found to be antigenically related to those from type A particles. The bioassay studies carried out with purified A particles showed that 2/7 males of strain ICRC and 1/6 females of strain DBA-MTI developed leukaemias, as against none in the controls, when inoculated between the ages of 1-7 days. Spleen tumour and cervical tumour were seen in one female each of strain DBA-MTI.
K A Karande, and
B J Joshi, and
V R Talageri, and
R U Dumaswala, and
K J Ranadive
January 1977,
Experimentelle Pathologie,
K A Karande, and
B J Joshi, and
V R Talageri, and
R U Dumaswala, and
K J Ranadive
June 1964,
Virology,
K A Karande, and
B J Joshi, and
V R Talageri, and
R U Dumaswala, and
K J Ranadive
January 1965,
Tumori,
K A Karande, and
B J Joshi, and
V R Talageri, and
R U Dumaswala, and
K J Ranadive
January 1983,
Neoplasma,
K A Karande, and
B J Joshi, and
V R Talageri, and
R U Dumaswala, and
K J Ranadive
January 1976,
Acta biologica et medica Germanica,
K A Karande, and
B J Joshi, and
V R Talageri, and
R U Dumaswala, and
K J Ranadive
April 1977,
Journal of the National Cancer Institute,
K A Karande, and
B J Joshi, and
V R Talageri, and
R U Dumaswala, and
K J Ranadive
April 1973,
Journal of virology,
K A Karande, and
B J Joshi, and
V R Talageri, and
R U Dumaswala, and
K J Ranadive
February 1976,
Journal of the National Cancer Institute,
K A Karande, and
B J Joshi, and
V R Talageri, and
R U Dumaswala, and
K J Ranadive
September 1964,
Nature,
K A Karande, and
B J Joshi, and
V R Talageri, and
R U Dumaswala, and
K J Ranadive
December 1976,
The Indian journal of medical research,
